Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Prostatic Neoplasms × Prednisolone × Clear all

Status

Completed 16 Recruiting 4 Active not recruiting 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lymphoma, Follicular 3 Lymphoma 2 Hemangioma 2 Prostatic Neoplasms 1

Interventions

Docetaxel 48 Prednisone 27 Leuprolide 21 enzalutamide 19 bicalutamide 15 Magnetic Resonance Spectroscopy 14 Goserelin 12 Abiraterone Acetate 12 Radiotherapy 11 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 10 abiraterone 9 cabazitaxel 8 Radiotherapy, Intensity-Modulated 8 olaparib 7 gallium 68 PSMA-11 7 Metformin 7 Ketoconazole 7 Gonadotropin-Releasing Hormone 7 Doxorubicin 7 Cyclophosphamide 7 Androgen Antagonists 7 luprolide acetate gel depot 6 Estramustine 6 pembrolizumab 5 cabozantinib 5 apalutamide 5 Radiosurgery 5 Mitoxantrone 5 Dexamethasone 5 Carboplatin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02125617 2026-01-14

uPARCRPC

Rigshospitalet, Denmark

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡